Paul Sharer has 25 years of intellectual property experience in developing and managing patent portfolios for complex technologies in strategic industries to support investment growth and exploitation of patent rights. He has particular experience in specialty chemicals, pharmaceuticals, biotechnologies, drug delivery, medical devices, software, cybersecurity, blockchain, and financial services. Paul advises start-ups, emerging companies, multinational corporations, and financial market corporations in developing and maintaining strategic patent estates.
Paul has extensive experience in assisting clients with worldwide intellectual property protection strategies as well as post-grant procedures (PGR [post-grant review], IPR [inter partes review]), patent litigation, and licensing/settlements. His experience includes patentability, infringement/noninfringement, validity/nonvalidity, freedom-to-operate/clearance, and prelitigation opinions. He has obtained more than 800 patents for clients in a wide variety of technological arts including software, cybersecurity, blockchain, financial services technologies, pharmaceuticals, medical devices, medical diagnostics, combination therapies, research diagnostics (assays), biotechnology, DNA and protein diagnostics, disease markers, nanotechnology, gene shuffling, small molecule drugs, drug delivery, coatings, organic chemistry, polymers, additives, active plant extracts, biodiagnostic tools, adjuvents, surfactants, consumer products, health care and personal care, and business methods (financial instruments, banking, and insurance).
Paul frequently works with clients to provide design around, offensive and defensive portfolio strategies, and other litigation avoidance counseling. He has conducted numerous IP due diligences for licensing, financial investment, prelitigation, and acquisitions projects. In addition, Paul has served as a guest lecturer at Georgetown Law and is a frequent speaker on intellectual property matters and provides in-house training for technical staff and counsel.
Legal Affairs–A New Dimension in Biotechnology Patent Portfolio Management, coauthor, Genetic and Engineering News
International Patents and International Harmonization, coauthor, BioPharma International
Chapter 5 – Protecting Intellectual Property in E-Commerce Software Patents, coauthor, E-Commerce Financial Products & Services, Smith, Law Journal Press
- June 22, 2011
Executive Roundtable Series - Growing Your Business: How to Handle Legal and Regulatory Hurdles Both Before and After They Arise
- September 15, 2010
Mastering Mergers and Acquisitions, NBI Webcast
- September 28, 2007
Resolving Technology and Media Disputes Before Trial 2007
Intellectual Property Considerations for Preventing or Anticipating, Patent Litigation and Protection: A Forum for the Pharmaceutical, Biotechnology, and Biopharma Counsel
Doing Business in China: Legal and Political Issues, Succeeding in China Seminar by JPMorganChase
A Practitioner’s Look at the Patent Process, GTCBIO Conference on VACCINES: From Political, Socio-Economic, Scientific, Provider, User and Legal Viewpoints
Described by clients as a "fine lawyer who thinks outside the box."Chambers
- Widener University (J.D. 1991); Drexel University (B.S. in Chemical Engineering 1985)
- District of Columbia and registered to practice before the United States Patent and Trademark Office
Featured in the cover story of the Business Section of The Washington Post article entitled "Wanted: Legal Superstars" (2004)
Recognized by the prestigious Chambers & Partners as one of "America's Leading Lawyers for Business" numerous times